Prof. Dr. Peter Gmeiner

Lehrstuhl für Pharmazeutische Chemie

Development of a random background to understand ligand optimization (2026) Xu X, Mailhot O, Correy GJ, Huang XP, Braz JM, Shi D, Srinivasan K, et al. Journal article Development of pH-Sensitive β-Adrenergic Receptor Antagonists (2026) Braun T, Pröll T, Weißing N, Hübner H, Gmeiner P Journal article Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity (2026) Panel N, Vo DD, Hübner H, Deluigi M, Pach S, Bélair F, Weikert D, et al. Journal article A Selectfluor-based Polonovski Rearrangement Leading to Novel Entities for Synthetic and Medicinal Applications (2026) Kuhn J, Gradl S, Osterloh V, Gmeiner P, Hübner H, Heinrich M Journal article Neurotensin receptor 2 agonism attenuates adverse cardiac remodeling in preclinical models (2026) Shiva N, Kawase H, Einsiedel J, Kwon J, Kumar S, Shao J, Du Z, et al. Journal article Towards “unmakable” psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy (2025) Stirn J, Berger R, Hübner H, Gmeiner P, Klein CD Journal article Hunting for lubeluzole analogues as antimyotonic agents with reduced cardiac liability (2025) Cavalluzzi MM, Gualdani R, Farinato A, Altamura C, Pierno S, Rotondo NP, Terlizzi F, et al. Journal article SAG1.3-derived Frizzled-targeting small-molecule compounds (2025) Grätz L, Turku A, Kozielewicz P, Bowin CF, Scharf MM, Voss JH, Kinsolving J, et al. Journal article Mechanism and function of GPR3 regulated by a negative allosteric modulator (2025) Chen G, Bláhová J, Staffen N, Hübner H, Nunhöfer N, Qiu C, Gmeiner P, et al. Journal article Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia (2025) Chestnykh D, Mühle C, Schumacher F, Kalinichenko L, Löber S, Gmeiner P, Alzheimer C, et al. Journal article